Nova Eye Medical Limited

ASX:EYE Rapport sur les actions

Capitalisation boursière : AU$35.5m

Nova Eye Medical Gestion

Gestion contrôle des critères 3/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Tom Spurling

Directeur général

AU$291.1k

Rémunération totale

Pourcentage du salaire du PDG84.3%
Durée du mandat du directeur général4.3yrs
Propriété du PDG0.4%
Durée moyenne d'occupation des postes de direction6.2yrs
Durée moyenne du mandat des membres du conseil d'administration6.3yrs

Mises à jour récentes de la gestion

Recent updates

We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth

Nov 04
We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth

Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%

Sep 22
Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%

Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Aug 06
Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Apr 18
Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

Mar 26
Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Jan 19
News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

Dec 27
Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Sep 03
We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Apr 17
Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

Dec 16
Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Aug 27
We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Analyse de la rémunération des PDG

Comment la rémunération de Tom Spurling a-t-elle évolué par rapport aux bénéfices de Nova Eye Medical?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024AU$291kAU$245k

-AU$9m

Mar 31 2024n/an/a

-AU$12m

Dec 31 2023n/an/a

-AU$14m

Sep 30 2023n/an/a

-AU$15m

Jun 30 2023AU$253kAU$211k

-AU$15m

Mar 31 2023n/an/a

-AU$13m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$9m

Jun 30 2022AU$311kAU$191k

-AU$7m

Mar 31 2022n/an/a

-AU$7m

Dec 31 2021n/an/a

-AU$6m

Sep 30 2021n/an/a

-AU$5m

Jun 30 2021AU$72kAU$66k

-AU$4m

Dec 31 2020n/an/a

-AU$9m

Sep 30 2020n/an/a

-AU$10m

Jun 30 2020n/an/a

-AU$10m

Dec 31 2019n/an/a

-AU$6m

Sep 30 2019n/an/a

-AU$6m

Jun 30 2019AU$328kAU$306k

-AU$7m

Mar 31 2019n/an/a

-AU$7m

Dec 31 2018n/an/a

-AU$6m

Sep 30 2018n/an/a

-AU$6m

Jun 30 2018AU$329kAU$300k

-AU$5m

Rémunération vs marché: La rémunération totale de Tom ($USD 189.16K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché Australian ($USD 297.90K ).

Rémunération et revenus: La rémunération de Tom a augmenté alors que l'entreprise n'est pas rentable.


PDG

Tom Spurling (62 yo)

4.3yrs

Titularisation

AU$291,117

Compensation

Mr. Thomas H. Spurling, also known as Tom, BSc (Hons), Ph D., FRACI, FTSE, AM is an Executive Director at Nova Eye Medical Limited since August 31, 2020 and serves as its Managing Director. Mr. Spurling wa...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Victor Previn
Founder & Executive Chairman23.3yrsAU$254.51kpas de données
Thomas Spurling
MD & Executive Directorno dataAU$291.12k0.37%
A$ 131.0k
Kimberley Menzies
Chief Financial Officerno datapas de donnéespas de données
Mark Flynn
Investor Relationsno datapas de donnéespas de données
Kate Hunt
Chief Commercial Officerno datapas de donnéespas de données
David Lubeck
Chief Medical Officer6.1yrspas de donnéespas de données
Joaquin Wolff
President of Ellex iTrack6.3yrspas de donnéespas de données
Simon Jeremy Gray
Company Secretary4.4yrspas de donnéespas de données
Don Watton
Vice President of Global Serviceno dataAU$143.97kpas de données
Meera Verma
Advisor to the Boardno dataAU$243.97kpas de données

6.2yrs

Durée moyenne de l'emploi

66yo

Âge moyen

Gestion expérimentée: L'équipe dirigeante de EYE est chevronnée et expérimentée (6.2 années d'ancienneté moyenne).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Victor Previn
Founder & Executive Chairman23.3yrsAU$254.51kpas de données
Thomas Spurling
MD & Executive Director4.3yrsAU$291.12k0.37%
A$ 131.0k
Rahmon Coupe
Independent Director11.5yrsAU$55.50k0.59%
A$ 207.9k
Michael Southard
Non Executive Director6.3yrsAU$61.05k0.0087%
A$ 3.1k
Daniel Webb
Independent Director2yrsAU$61.05k0.24%
A$ 86.1k

6.3yrs

Durée moyenne de l'emploi

62yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de EYE sont considérés comme expérimentés (ancienneté moyenne 6.3 ans).